Lv1
40 积分 2024-09-05 加入
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
1天前
待确认
Acute urticaria management: Gaps, challenges and the need for further evidence
5天前
已完结
Omalizumab for the Treatment of Refractory Acute Urticaria
5天前
已完结
Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate‐to‐severe atopic dermatitis
15天前
已完结
Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry
15天前
已完结
Effect of upadacitinib on atopic hand eczema in patients with moderate‐to‐severe atopic dermatitis: Results from two randomized phase 3 trials
15天前
已完结
Treatment of Refractory Hand and Foot Eczema with Nail Involvement Using Upadacitinib: A Case Report
15天前
已关闭
Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choices
22天前
已关闭
Inflammasome activation in patients with Kaposi sarcoma herpesvirus (KSHV)-associated disorders
1个月前
已关闭
Is inflammation key in Kaposi sarcoma?
1个月前
已完结
皖公网安备34019202002308
